BCIQ Profiles

Company Profile Report

DNDi, partners aim to bring cheaper HCV combo to Latin America

The Drugs for Neglected Diseases initiative said it will partner with three pharmaceutical companies and a non-profit to sell a cheaper HCV regimen in Latin America. HCV patients pay at least $7,000 in Argentina, $12,000 in

Read the full 369 word article

How to gain access

Continue reading with a
two-week free trial.